Life Science Instrumentation Market Report 2026

The life science instrumentation market size has grown strongly in recent years. It will grow from $70.86 billion in 2025 to $75.77 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to expansion of pharmaceutical and biotechnology research activities, increasing investments in laboratory infrastructure, growth in genomics and proteomics research, adoption of advanced diagnostic instruments, rising demand for accurate analytical results.

The life science instrumentation market size is expected to see strong growth in the next few years. It will grow to $97.89 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing use of automated and connected instruments, rising demand for personalized medicine research tools, expansion of clinical diagnostics testing, growing adoption of AI-enabled instrumentation, increasing investments in next-generation laboratory technologies. Major trends in the forecast period include increasing adoption of high-throughput analytical instruments, rising integration of automation in laboratory workflows, growing demand for precision measurement technologies, expansion of multi-omics research instrumentation, enhanced focus on data-integrated lab systems.

The rising prevalence of genetic disorders is anticipated to drive the growth of the life science instrumentation market in the coming years. Genetic disorders are conditions caused by abnormalities in an individual's DNA or chromosomes. Their occurrence is increasing due to advancements in diagnostic technologies, greater awareness, and changes in reproductive patterns. Life science instruments are employed to diagnose, monitor, and develop targeted therapies for patients with genetic disorders by analyzing genetic material and biomarkers. For example, in May 2023, the Alzheimer Society, a UK-based dementia care and research charity, reported that around 982,000 people in the UK were living with dementia, a number expected to rise to 1.4 million by 2040. Consequently, the growing prevalence of genetic disorders is fueling demand in the life science instrumentation market.

Key players in the life science instrumentation market are concentrating on developing innovative solutions, such as high-performance mass spectrometers with ultrahigh sensitivity, to enhance workflows in proteomics, metabolomics, translational research, and precision medicine. High-performance mass spectrometers are analytical devices that detect and quantify molecules, including proteins, metabolites, and lipids, by ionizing them and measuring their mass-to-charge ratios. Compared with conventional instruments, these advanced systems offer higher sensitivity, faster analysis, and greater throughput, supporting complex biological and clinical studies with improved accuracy. For instance, in June 2023, Thermo Fisher Scientific Inc., a US-based life science instrumentation company, introduced the Thermo Scientific Orbitrap Astral mass spectrometer, an advanced system delivering deep proteome coverage, high resolution, and accelerated throughput for biomarker discovery and proteomics research. The Astral mass spectrometer enables detection of low-abundance proteins, quicker processing of large sample batches, and stronger support for translational and basic research, providing significant performance enhancements over traditional MS platforms in terms of sensitivity, efficiency, and data quality.

In January 2024, Calibre Scientific Inc., a US-based life sciences and diagnostics company, acquired Labtech International Ltd. for an undisclosed sum. This acquisition allows Calibre Scientific to broaden its portfolio of analytical instruments while strengthening its presence and service capabilities across the British Isles. Labtech International Ltd. is a UK-based manufacturer and supplier of laboratory instruments and equipment, specializing in life sciences and scientific research.

Major companies operating in the life science instrumentation market are Thermo Fisher Scientific Inc, Agilent Technologies Inc, Danaher Corporation, Bruker Corporation, Shimadzu Corporation, Waters Corporation, PerkinElmer Inc, Bio-Rad Laboratories Inc, JEOL Ltd, Horiba Ltd, Eppendorf AG, Tecan Group AG, Leica Microsystems AG, Sartorius AG, Illumina Inc, Oxford Instruments plc, Becton Dickinson and Company, Beckman Coulter Inc, Carl Zeiss AG, Nikon Corporation, Hitachi High Technologies Corporation.

North America was the largest region in the life science instrumentation market in 2025. The regions covered in the life science instrumentation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the life science instrumentation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the life science instrumentation market by increasing costs of imported optical components, electronic modules, precision sensors, and mechanical assemblies used in spectroscopy, chromatography, PCR, and microscopy systems. Research institutions and pharmaceutical manufacturers in North America and Europe are most affected due to reliance on imported high-precision components, while Asia-Pacific faces cost pressures on instrument exports. These tariffs are increasing capital expenditure and delaying laboratory upgrades. However, they are also promoting localized instrument assembly, regional component sourcing, and long-term investment in domestic manufacturing capabilities.

The life science instrumentation market research report is one of a series of new reports that provides life science instrumentation market statistics, including life science instrumentation industry global market size, regional shares, competitors with a life science instrumentation market share, detailed life science instrumentation market segments, market trends and opportunities, and any further data you may need to thrive in the life science instrumentation industry. This life science instrumentation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Life science instrumentation encompasses a variety of tools and devices utilized for research and analysis within the biological and medical sciences. These instruments enable scientists to study the structure, function, and interactions of biological molecules, cells, and organisms. They are widely employed in areas such as genomics, proteomics, cell analysis, and drug development.

The primary categories of life science instrumentation include spectroscopy, chromatography, polymerase chain reaction, immunoassays, lyophilization, liquid handling, clinical chemistry analyzers, microscopy, flow cytometry, and more. Spectroscopy is a method used to assess the interaction between light and matter, offering insights into the composition, structure, and characteristics of substances. It involves examining the spectrum of light that is emitted, absorbed, or scattered by materials. These instruments find applications across multiple domains, including research, clinical and diagnostic use, and others. Typical end users consist of hospitals and diagnostic laboratories, pharmaceutical and biotechnology firms, academic and research institutions, agriculture and food industries, environmental testing laboratories, clinical research organizations, and more.

The life science instrumentation market consists of sales of electrophoresis apparatus, polymerase chain reaction machines, chromatographs, and robotic liquid handlers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.